Physician profile
Sara Cox
NPI 1851765226
$1,515.30
in general payments reported to CMS, 2019-2025
16 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $260 · 2022: $118 · 2023: $394 · 2024: $330 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,136.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $281.45 | 2021-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $251.39 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $212.13 | 2021-2025 | Mounjaro, Zepbound |
| Xeris Pharmaceuticals, INC. | $189.51 | 2021-2025 | Gvoke Hypopen |
| Amgen INC. | $120.72 | 2023-2025 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.76 | 2021-2025 | Jardiance, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $62.19 | 2024-2025 | |
| Corcept Therapeutics | $55.65 | 2025 | Korlym |
| Dexcom, INC. | $52.35 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $51.96 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $47.40 | 2023-2024 | Trelegy Ellipta, Shingrix |
| Daiichi Sankyo INC. | $40.13 | 2021 | |
| Janssen Biotech, INC. | $34.20 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $21.46 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.42 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.